Verified Nov 2026
Other
·
Gothenburg, Vaestra Goetaland County
·
Since 2009
Sobi is a Swedish biopharmaceutical company founded in 2009 and headquartered in Gothenburg, with 1,000–5,000 employees and estimated revenue of SEK 28 billion in 2025. The company develops and distributes medicines for rare and debilitating diseases, focusing on haematology, immunology, and specialty care. Sobi completed the acquisition of Arthrosi Therapeutics in February 2026 to expand its pipeline for gout treatment.
Sobi - Swedish Orphan Biovitrum AB (publ) at a glance
Revenue
$1-5B
Est. band
Employees
1,000-5,000
Founded
2009
Headquarters
Gothenburg, Vaestra Goetaland County
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Sobi is a Swedish biopharmaceutical company founded in 2009 and headquartered in Gothenburg, with 1,000–5,000 employees and estimated revenue of SEK 28 billion in 2025. The company develops and distributes medicines for rare and debilitating diseases, focusing on haematology, immunology, and specialty care. Sobi completed the acquisition of Arthrosi Therapeutics in February 2026 to expand its pipeline for gout treatment.
At a glance
Attribute | Detail |
|---|---|
Founded | 2009 |
Headquarters | Gothenburg, Vaestra Goetaland County |
Employees | 1,000-5,000 |
Revenue | $1-5B (estimated) |
What Sobi - Swedish Orphan Biovitrum AB (publ) makes
Sobi's product portfolio includes treatments such as Alprolix for haemophilia B, Gamifant for hemophagocytic lymphohistiocytosis, and Synagis for prevention of respiratory syncytial virus in infants.
Latest developments
2026-10-28 — Latest Sobi News & Announcements | Distill (distillintelligence.com)
2026-09-16 — Sobi and Innate announce partnership is now effective following completion of closing conditions - Swedish Orphan Biovitrum AB (cision.com)
2026-08-10 — Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma | Sobi (sobi.com)
2026-02-18 — Sobi Capital Markets Day 2026: Bringing brilliant ideas to life and building the next chapter with ambition to deliver SEK 55bn by 2030 (prnewswire.com)
2026-02-09 — Sobi completes acquisition of Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout | Sobi (sobi.com)
2026-02-05 — Interim Report Q4 2025 | Sobi (sobi.com)
Facilities
Sobi - Swedish Orphan Biovitrum AB (publ) is headquartered in Gothenburg, Vaestra Goetaland County. Public sources also reference these locations:
Stockholm, Sweden — sobi.com
Company details
In September 2026, Sobi and Innate Pharma completed a partnership agreement for the licensing of lacutamab in T-cell lymphoma, following the company's stated ambition to deliver SEK 55 billion in revenue by 2030. Sobi - Swedish Orphan Biovitrum AB (publ) was founded in 2009, has an estimated 1,000-5,000 employees, and is headquartered in Gothenburg, Vaestra Goetaland County.
Frequently asked questions
What does Sobi - Swedish Orphan Biovitrum AB (publ) do?
Sobi is a Swedish biopharmaceutical company founded in 2009 and headquartered in Gothenburg, with 1,000–5,000 employees and estimated revenue of SEK 28 billion in 2025. The company develops and distributes medicines for rare and debilitating diseases, focusing on haematology, immunology, and specialty care. Sobi completed the acquisition of Arthrosi Therapeutics in February 2026 to expand its pipeline for gout treatment.
Where is Sobi - Swedish Orphan Biovitrum AB (publ) headquartered?
Sobi - Swedish Orphan Biovitrum AB (publ) is headquartered in Gothenburg, Vaestra Goetaland County.
When was Sobi - Swedish Orphan Biovitrum AB (publ) founded?
Sobi - Swedish Orphan Biovitrum AB (publ) was founded in 2009.
How big is Sobi - Swedish Orphan Biovitrum AB (publ)?
Sobi - Swedish Orphan Biovitrum AB (publ) has an estimated 1,000-5,000 employees, with revenue in the $1-5B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
